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Dog Breed Age (years) Sex 
Coated platelets 
(%) 
1 German wirehaired 
pointer 
5 MC 24.5 
2 Pit bull terrier 5.5 FS 22.0 
3 Rough-coated 
collie 
5 MC 45.4 
4 Mixed breed 6 FS 46.3 
5 Golden retriever 4 FS 30.9 
6 Greyhound 9 FS 15.1 
7 Labrador retriever 6 MC 32.8 
8 Labrador retriever 2 FS 46.2 
9 Mixed breed dog 8 MC 49.5 
10 Border collie 5 MC 24.5 
11 Australian 
shepherd 
5 FS 15.4 
12 Australian 
shepherd 
2 MC 23.8 
13 Mixed breed dog 1 MC 21.7 










1$ 11& FS& NonIremission& Lymphoma& Cytology& Unknown& V& b& 413& 25.5&
2$ 8& FS& NonIremission& Lymphoma& Histopathology& TIcell&& II& a& 235& 23.7&
3$ 7& FS& NonIremission& Lymphoma& Cytololgy&&&flow&
cytometry&&
BIcell& III& a& 445& 30.0&
4$ 14& MC& NonIremission& Lymphoma& Cytology&&&PARR& TIcell&& II& b& 506& 63.3&
5$ 4& MI& NonIremission& Lymphoma& Histopathology& BIcell& III& b& 239& 10.3&
6$ 10& MC& NonIremission& Lymphoma& Cytology&&&flow&cytometry& BIcell& III& a& 222& 36.0&
7$ 15& FS& NonIremission& Lymphoma& Cytology&&&flow&cytometry& BIcell& III& a& 406& 32.1&
8$ 8& MC& NonIremission& Lymphoma& Cytology&&&flow&cytometry& BIcell& III& a& 149& 14.7&
9$ 8& FS& NonIremission& Lymphoma& Cytology&&&flow&cytometry& TIcell& V&& a& 230& 51.2&
10$ 9& FS& NonIremission& Lymphoma& Cytology&&&flow&cytometry& BIcell& IV& b& 124& 4.5&
11$ 8& MC& NonIremission& Lymphoma& Histopathology& Unknown& II& a& 201& 19.6&
12$ 13& FS& NonIremission& Lymphoma& Cytology&&&histopathology& TIcell& III& a& 404& 10.5&
13$ 10& FS& NonIremission& Leukemia& Cytology&&&flow&cytometry& TIcell& n/a& n/a& 352& 48.0&
14$ 11& FS& Remission& Lymphoma& Cytology&&&flow&cytometry& BIcell& V& b& 667& 46.6&
15$ 7& MC& Remission& Lymphoma& Cytology&&&flow&cytometry& BIcell& III& b& 278& 21.5&
16$ 12& MC& Remission& Lymphoma& Cytology&&&flow&cytometry& BIcell& III& b& 183& 48.8&
17$ 3& MC& Remission& Lymphoma& Histopathology& Unknown& V& b& 235& 29.6&
18$ 14& FI& Remission& Lymphoma& Cytology&&&flow&cytometry& BIcell& IV&& b& 192& 26.4&
19$ 6& MC& Remission& Lymphoma& Cytology& Unknown& III& a& 325& 48.8&










Dog$ Breed& Age&(years)& Sex& Remission&
status&
Classification& Diagnostic&method& Platelet&count& Average&coated&
platelets&(%)&
1$ Mixed&breed& 8& FS& NR& Chondrosarcoma& Histopathology& 279& 56&
2$ Boston&terrier& 9& MI& NR& MCT& Cytology& 428& 56.47&
3$ English&setter& 10& MC& NR& Osteosarcoma& Cytology& 392& 33.75&
4$ Mixed&breed& 13& FS& R& Clear&cell&adnexal&
carcinoma&
Histopathology& 545& 43.97&
5$ Golden&retriever& 8& MC& NR& Hemangiosarcoma& Histopathology& 286& 43.9&
6$ German&
shepherd&&
8& MC& R& Anal&sac&
adenocarcinoma&
Histopathology& 262& 43.13&
7$ Golden&retriever& 11& MC& NR& Chondrosarcoma& Histopathology& 284& 34.73&
8$ English&springer&
spaniel&






7& FS& NR& Osteosarcoma& Cytology&&&histopathology& 167& 28.47&
10$ Australian&
shepherd&
8& MC& NR& Insulinoma& Glucose/insulin&levels,&CT&scan& 367& 26.27&
11$ Mixed&breed& 9& MC& NR& Insulinoma& Histopathology& 408& 37&
12$ Boxer& 5& MC& NR& Oligodendroglial&
ganglioglioma&
Histopathology& 272& 46.27&




































4$ Lymphoma& n/a& n/a& Nasal&congestion,&suspect&
nasal&mass&
n/a& 63.3&
5$ Lymphoma& n/a& n/a& None& Doxycycline& 10.3&


















8$ Lymphoma& n/a& n/a& None& n/a& 14.7&
9$ Lymphoma& Revised&MOPP& Prednisone& Head&tilt& n/a& 51.2&
10$ Lymphoma& CHOP& Prednisone& None& n/a& 4.5&















13$ Leukemia& Chlorambucil&& Prednisone& Urinary&incontinence& n/a& 48.0&
14$ Lymphoma& CHOP&& Prednisone& Hypothyroid,&arthritis& Gabapentin,&
soloxine&&
46.6&







n/a& None& SAMe,&TMS& 48.8&
17$ Lymphoma& CHOP& Prednisone& None& Cerenia& 29.6&
18$ Lymphoma& CHOP& Prednisone& None& n/a& 26.4&
























1$ Chondrosarcoma& n/a& n/a& None& None& 56&
2$ MCT& n/a& n/a& Atopy& Cyclosporine& 56.47&
3$ Osteosarcoma& n/a& n/a& None& None& 33.75&
4$ Clear&cell&adnexal&
carcinoma&
n/a& n/a& Osteoarthritis& None& 43.97&




















n/a& n/a& None& None& 48.6&
9$ Osteosarcoma& n/a& n/a& None& Fish&oil& 28.47&









n/a& n/a& None& Leviteracetam& 46.27&
13$ Anal&sac&
adenocarcinoma&
n/a& n/a& None& None& 45.2&
14$ Nasal&
adenocarcinoma&
n/a& Prednisone& Previous&history&
of&aspergillosis;&
recent&onset&
seizures&
Clavamox,&
phenobarbital&
40&
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CHAPTER(4.(CONCLUSIONS(
Brief(summary(
In(summary,(this(thesis(describes(two(projects(involving(canine(platelets.((In(the(first,(a(
novel(canine(immune(thrombocytopenia((ITP)(bleeding(score,(the(DOGiBAT,(was(developed(and(
validated.((An(ITP(bleeding(score(will(allow(more(objective(comparisons(of(clinical(bleeding,(
especially(in(multicenter(studies,(and(will(allow(stratification(of(ITP(patients(in(clinical(trials(
based(on(their(bleeding(severity(to(provide(an(objective(comparison(of(outcome(among(
treatment(protocols.(In(the(second(project,(coated(platelet(potential(in(canine(cancer(patients(
was(investigated.((Coated(platelets(are(a(subset(of(platelets(that(are(formed(ex#vivo(by(dual(
stimulation(with(thrombin(and(rattlesnake(toxin.((In(that(study,(we(found(that(dogs(with(solid(
tumors(formed(a(greater(percentage(of(coated(platelets(compared(with(healthy(control(dogs.((
Future(directions(
There(are(several(future(directions(elucidated(in(this(thesis.((First,(future(application(of(
the(DOGiBAT(bleeding(score(system(to(prospective(clinical(trials(comparing(treatments(for(
canine(ITP(should(be(considered.((This(could(have(a(major(clinical(impact,(as(the(current(ideal(
treatment(for(ITP(is(not(known,(and(the(DOGiBAT(could(help(objectively(compare(treatment(
outcome.((Application(of(the(DOGiBAT(could(also(allow(clinicians(to(individualize(treatment(
based(on(a(patient’s(bleeding(risk(or(bleeding(severity,(thereby(reducing(both(underRtreating(
and(overRtreating,(both(of(which(have(potential(for(complications.((Further(studies(involving(
coated(platelet(potential(in(canine(patients(should(also(be(considered.((One(limitation(of(the(
study(reported(herein(was(the(relatively(small(sample(size,(especially(considering(the(
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heterogeneous(nature(of(the(patients(in(this(study.((Coated(platelets(should(be(investigated(in(a(
more(homogenous(group(of(canine(cancer(patients.((Additionally,(the(role(of(coated(platelets(
could(be(investigated(in(other(diseases(known(to(be(associated(with(hypercoagulability(such(as(
hyperadrenocorticism,(proteinRlosing(nephropathy,(etc.(Finally,(coated(platelets(could(be(
investigated(as(a(potential(therapeutic(target,(such(as(with(SSRIs(in(canine(cancer(patients.(((
